Home
Conditions
Influenza, Human

Clinical trial condition

Influenza, Human

Explore clinical trials studying Influenza, Human. Study availability and eligibility vary by location and protocol.

1,849 public trials 84 recruiting studies

Refine in advanced search Browse all conditions

Influenza, Human trial results

Completed

Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age

NCT01974895

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Sacramento, California, United States

GSK Investigational Site West Covina, California, United States

GSK Investigational Site Altamonte Springs, Florida, United States

GSK Investigational Site Fall River, Massachusetts, United States

View Trial Details

Completed

A Study to Evaluate the Safety and Immunogenicity of a Prime-boost Schedule of GSK Biologicals' Influenza Vaccine in Children

NCT01379937

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Alabang, Muntinlupa, Philippines

GSK Investigational Site Quezon City, Philippines

View Trial Details

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Fluviral® (2012/2013 Season) in Adults

NCT01626820

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Sherbrooke, Quebec, Canada

View Trial Details

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345

NCT01702454

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Děčín, Czechia

GSK Investigational Site Jindřichův Hradec, Czechia

GSK Investigational Site Lipník nad Bečvou, Czechia

GSK Investigational Site Náchod, Czechia

View all 33 locations

View Trial Details

Completed

Safety and Immune Response of Candidate H1N1 Influenza Vaccines GSK2340274A and GSK234072A in Children 3 to Less Than 10 Years Old

NCT01161160

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Sampaloc, Manila, Philippines

GSK Investigational Site Bangkok, Thailand

View Trial Details

Completed

Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults

NCT01811823

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +23 more
Locations: Respiratory and Meningeal Pathogens research unit Johannesburg, Gauteng, South Africa

View Trial Details

Completed

Immune Response and Risk of Side Effects After Influenza Vaccination in Athletes

NCT03654937

Conditions: Infections, Influenza Vaccine Allergy, Influenza Virus Vaccine Adverse Reaction, +6 more
Locations: Not specified

View Trial Details

Completed

Response of Older Adults to Influenza Vaccination With Regard to Cytomegalovirus (CMV) Status

NCT00442975

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Hertfordshire Primary Care Trust Stevenage, United Kingdom

View Trial Details

Completed

4 Pillars Toolkit for Adolescent Vaccination

NCT02165722

Conditions: Adolescent HPV Vaccine, Adolescent Influenza Vaccine, Infections, +6 more
Locations: University of Pittsburgh, School of Medicine, Department of Family Medicine Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

H7N9 Boost in Healthy Adults

NCT02586792

Conditions: Animal Diseases, Bird Diseases, Infections, +8 more
Locations: Baylor College of Medicine - Molecular Virology and Microbiology Houston, Texas, United States

View Trial Details

Influenza, Human

Influenza, Human trial results

Related conditions